Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. News
  7. All News
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about NANOFORM FINLAND OYJ
08/03NANOFORM FINLAND OYJ : and Boehringer Ingelheim execute master services agreemen..
AQ
08/03Nanoform and Boehringer Ingelheim Execute Master Services Agreement
CI
06/14NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrad..
PU
06/14NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
06/11NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multi..
PU
06/11NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on..
AQ
06/11NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multi..
AQ
06/02NANOFORM FINLAND OYJ : Upgrades Business Targets For 2025; Shares Up 8%
MT
06/02NANOFORM FINLAND OYJ : raises its mid-term business targets for 2025
AQ
05/29Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement End..
CI
05/27NANOFORM FINLAND OYJ : Interim Report January – March (Q1) 2021
PU
05/27NANOFORM FINLAND OYJ : Interim Report January - March (Q1) 2021
AQ
05/27Nanoform Finland Oyj Reports Earnings Results for the First Quarter Ended Mar..
CI
05/25NANOFORM FINLAND OYJ : and Celanese Explore Ways to Enhance Drug Delivery
AQ
05/20NANOFORM FINLAND OYJ : Cynthia Schwalm transitions to Senior Advisor Business De..
AQ
05/20Cynthia Schwalm Resigns from Nanoform's Board of Directors
CI
05/18NANOFORM FINLAND OYJ : final clinical results confirm value proposition to the p..
PU
05/18NANOFORM FINLAND OYJ : final clinical results confirm value proposition to the p..
AQ
05/18Nanoform Announces Completion and Final Results of Clinical Study
CI
05/12NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's Q1/2021 report o..
PU
05/12NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's Q1/2021 report o..
AQ
05/11NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on..
AQ
04/21NANOFORM FINLAND OYJ : Partners With Aprecia for 3D Printed Nanomedicines
MT
04/21NANOFORM FINLAND OYJ : and Aprecia collaborate to advance 3D printed Nanomedicin..
AQ
04/21Nanoform and Aprecia Collaborate to Advance 3D Printed Nanomedicines
CI
04/08NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrad..
PU
04/08NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
04/07NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multi..
PU
04/07NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multi..
AQ
04/06NANOFORM FINLAND OYJ : Resolutions of the Constitutive Meeting of the Board of D..
AQ
04/06Nanoform Finland Oyj Announces Audit and Compensation Committee Elections
CI
04/06NANOFORM FINLAND OYJ : Resolutions of Nanoform Finland Plc's Annual General Meet..
PU
04/06NANOFORM FINLAND OYJ : Resolutions of Nanoform Finland Plc's Annual General Meet..
AQ
03/31NANOFORM FINLAND OYJ : and Nacuity Pharmaceuticals Sign Technology Proof of Conc..
PU
03/31NANOFORM FINLAND OYJ : and Nacuity Pharmaceuticals Sign Technology Proof of Conc..
AQ
03/31Nanoform Finland Plc and Nacuity Pharmaceuticals Signs Technology Proof of Co..
CI
03/22NANOFORM FINLAND OYJ : launches next-generation STARMAP« v2.0, the AI-based dru..
AQ
03/22NANOFORM FINLAND OYJ : launches next-generation STARMAP v2.0, the AI-based drug ..
AQ
03/22Nanoform Finland Plc Launches Next-Generation STARMAP V2.0, the AI-Based Drug..
CI
03/10NANOFORM FINLAND OYJ : Notice to the annual general meeting of nanoform finland ..
AQ
03/10NANOFORM FINLAND PLC : 5 633 803 new shares registered with the trade register
AQ
03/09NANOFORM FINLAND PLC : successfully completes new share issue raising EUR 40 mil..
AQ
03/09NANOFORM FINLAND PLC : announces its intention to carry out a new share issue to..
AQ
02/26NANOFORM FINLAND OYJ : 1-12/2020 report and new company near-term target introdu..
AQ
02/26Nanoform Finland plc Reports Earnings Results for the Fourth Quarter and Full..
CI
02/26NANOFORM FINLAND OYJ : sets new near-term business target for 2021 and 2022
AQ
02/24NANOFORM FINLAND OYJ : Additional Positive Interim Results from Nanoform's Clini..
PU
02/24Nanoform Finland Announces Further Positive Interim Results from Its Ongoing ..
CI
02/24NANOFORM FINLAND OYJ : Additional Positive Interim Results from Nanoform's Clini..
AQ
02/23NANOFORM FINLAND OYJ : Annual Review 2020
PU
02/12NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's year-end report ..
PU
02/12NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's year-end report ..
AQ
02/09HERANTIS PHARMA OYJ : and Nanoform Enter into Agreement for Proof of Concept Col..
AQ
02/09NANOFORM FINLAND OYJ : and Herantis sign Biologics Proof of Concept Agreement
AQ
02/09Nanoform Finland Oyj and Herantis Sign Biologics Proof of Concept Agreement
CI
01/22NANOFORM FINLAND OYJ : Clinical Study Indicates Positive Interim Results
PU
01/22Nanoform's Clinical Study Indicates Positive Interim Results
CI
01/22NANOFORM FINLAND OYJ : Clinical Study Indicates Positive Interim Results
AQ
01/04NANOFORM FINLAND OYJ : sets a new near-term business target for 2021
AQ
2020NANOFORM FINLAND OYJ : included in Nasdaq First North 25 index as of Jan 4th, 20..
PU
2020NANOFORM FINLAND OYJ : First dosing of nanoformed drug successfully accomplished
AQ
2020Nanoform Finland plc Announces First Dosing of Nanoformed Drug Successfully A..
CI
2020HERANTIS PHARMA OYJ : and Nanoform Sign a Letter of Intent (LOI) for Collaborati..
AQ
2020NANOFORM FINLAND OYJ : and Herantis partner to look for opportunities to enhance..
AQ
2020Nanoform Finland Oyj and Herantis Partners to Look for Opportunities to Enhan..
CI
2020NANOFORM FINLAND OYJ : Notification of major shareholdings according to Nanoform..
PU
2020NANOFORM FINLAND OYJ : Notification of major shareholdings according to Nanoform..
AQ
2020NANOFORM FINLAND OYJ : makes US TV debut in Advancements with Ted Danson (CNBC)
AQ
2020Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement End..
CI
2020NANOFORM FINLAND OYJ : launches technology for biologics and sets new near-term ..
AQ
2020NANOFORM FINLAND OYJ : Interim Report for January-September 2020 – Report
PU
2020NANOFORM FINLAND OYJ : launches technology for biologics and sets new near-term ..
PU
2020Nanoform Finland Oyj Reports Earnings Results for the Third Quarter and Nine ..
CI
2020NANOFORM FINLAND PLC, INTERIM REPORT : 00 a.m. Finnish time
AQ
2020NANOFORM FINLAND OYJ : launches technology for biologics and sets new near-term ..
AQ
1  2Next